Adding the clinical framing, because it changes how the question reads.
Financial impact of cost and coverage weight loss beyond medication cost:
- Groceries: SAVED $234/month (eating less)
- Restaurants: SAVED $164/month (fewer meals out)
- Alcohol: SAVED $114/month (stopped drinking)
- Life insurance: Premium REDUCED by $44/month (lower BMI)
- Copays: SAVED $74/month (fewer BP/cholesterol meds)
Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.
Dr.PeteFamMed said:Insurance update relevant to cost and coverage: I just got my prior auth approved through UnitedHealthcare after 4 attempts.
Dr.PeteFamMed said:...regarding the discontinuation data for cost and coverage...
I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."
Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.
This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.
Following on from Dr.PeteFamMed — and this may be the naive question:
Was that from a primary source or from a summary of one?
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemHPLC_Greg said:Dr.PeteFamMed said: ...regarding the discontinuation data for cost and coverage...
This is where I part company with the consensus forming above. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.
Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Carry on.